These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet? Nzila A; Ochong E; Nduati E; Gilbert K; Winstanley P; Ward S; Marsh K Trans R Soc Trop Med Hyg; 2005 May; 99(5):341-6. PubMed ID: 15780340 [TBL] [Abstract][Full Text] [Related]
4. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment. Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990 [TBL] [Abstract][Full Text] [Related]
5. Intercontinental spread of pyrimethamine-resistant malaria. Roper C; Pearce R; Nair S; Sharp B; Nosten F; Anderson T Science; 2004 Aug; 305(5687):1124. PubMed ID: 15326348 [TBL] [Abstract][Full Text] [Related]
7. Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation. Hamel MJ; Poe A; Bloland P; McCollum A; Zhou Z; Shi YP; Ouma P; Otieno K; Vulule J; Escalante A; Udhayakumar V; Slutsker L Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):338-45. PubMed ID: 18321547 [TBL] [Abstract][Full Text] [Related]
8. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania. Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré. Bonnet M; Roper C; Félix M; Coulibaly L; Kankolongo GM; Guthmann JP Malar J; 2007 May; 6():54. PubMed ID: 17477865 [TBL] [Abstract][Full Text] [Related]
10. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833 [TBL] [Abstract][Full Text] [Related]
11. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh. Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306 [TBL] [Abstract][Full Text] [Related]
13. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine. Zakeri S; Farahani MS; Afsharpad M; Salehi M; Raeisi A; Djadid ND Int J Infect Dis; 2010 Sep; 14 Suppl 3():e123-8. PubMed ID: 20399698 [TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum dihydrofolate reductase alleles and pyrimethamine use in pregnant Ghanaian women. Mockenhaupt FP; Eggelte TA; Böhme T; Thompson WN; Bienzle U Am J Trop Med Hyg; 2001 Jul; 65(1):21-6. PubMed ID: 11504402 [TBL] [Abstract][Full Text] [Related]
15. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka. Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070 [TBL] [Abstract][Full Text] [Related]
16. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum. Biswas S J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993 [TBL] [Abstract][Full Text] [Related]
17. Surveillance of antifolate-resistant malaria. Basco LK; Tahar R; Ringwald P Lancet; 1998 Aug; 352(9125):406. PubMed ID: 9717957 [No Abstract] [Full Text] [Related]
18. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami. Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141 [TBL] [Abstract][Full Text] [Related]
19. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058 [TBL] [Abstract][Full Text] [Related]
20. Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania. Hastings MD; Bates SJ; Blackstone EA; Monks SM; Mutabingwa TK; Sibley CH Trans R Soc Trop Med Hyg; 2002; 96(6):674-6. PubMed ID: 12630380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]